NCT00787072 - AZD8075 Single Ascending Dose Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions

Healthy Volunteers

Interventions

DRUG

AZD8075

Single dose, the starting dose will be 7 mg, oral suspension, with up to 8 dose escalations not exceeding AstraZeneca pre-defined upper exposure limits.

DRUG

Placebo

Oral suspension

Trial Locations (1)

Unknown

Research Site, Uppsala